WO1992009267A1 - Methodes d'immobilisation de liposomes dans des billes de gel et materiaux similaires presentant des liposomes immobilisees prepares par ces methodes, et leurs utilisations - Google Patents

Methodes d'immobilisation de liposomes dans des billes de gel et materiaux similaires presentant des liposomes immobilisees prepares par ces methodes, et leurs utilisations Download PDF

Info

Publication number
WO1992009267A1
WO1992009267A1 PCT/SE1991/000788 SE9100788W WO9209267A1 WO 1992009267 A1 WO1992009267 A1 WO 1992009267A1 SE 9100788 W SE9100788 W SE 9100788W WO 9209267 A1 WO9209267 A1 WO 9209267A1
Authority
WO
WIPO (PCT)
Prior art keywords
liposomes
beads
gel
proteoliposomes
particles
Prior art date
Application number
PCT/SE1991/000788
Other languages
English (en)
Inventor
Qing Yang
Per Lundahl
Maria Sandberg
Eva Greijer
Original Assignee
Qing Yang
Per Lundahl
Maria Sandberg
Eva Greijer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qing Yang, Per Lundahl, Maria Sandberg, Eva Greijer filed Critical Qing Yang
Priority to JP4500582A priority Critical patent/JPH06505913A/ja
Publication of WO1992009267A1 publication Critical patent/WO1992009267A1/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/291—Gel sorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
    • B01J20/28016—Particle form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
    • B01J20/28047—Gels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00—Aspects relating to sorbent materials
    • B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
    • B01J2220/54—Sorbents specially adapted for analytical or investigative chromatography

Definitions

  • the present invention relates to methods of immobilizing liposomes or proteoliposomes in materials like gel beads, materials with immobilized liposomes or proteoliposomes prepared by such methods, and chromatographic, medical and other uses of such gel beads or similar materials with immobilized liposomes.
  • ipid bilayers prepared in the form of spherical vesicles, called liposomes, are commonly used as models of membranes in experimen ⁇ tal studies. Liposomes with membrane protein(s) in their lipid bilayers (proteoliposomes) are used for studies of protein- mediated transport across the bilayer.
  • Liposomes can be designed to have ion-exchange, affinity and transpor properties as well as catalytic activities.
  • Affinity ligands or catalytic macromolecules including transmembrane and peripheral membrane proteins can be hydrophobically anchored or inserted into the lipid bilayer.
  • liposomes are entrapped (sterically immobili ⁇ zed) in the gel beads by dialysing solubilized lipids together with the gel beads. The amount of entrapped liposomes increases non-linearly with the initial lipid concentration and is dependent on the relative sizes of liposomes and gel pores.
  • the novel method of the invention utilizes the effect or effects that when liposomes are fused or lipid material (for example fragments or micelles) are associated into liposomes, the newly formed liposomes are either sterically entrapped or entangled due to their relatively large size or they become otherwise entrapped or entangled in the three-dimensional network of the material used.
  • Preferred materials are gel beads or particles made of polysaccharides, such as agarose, dextran and glucomannan; polyacrylamide; allylpolysaccharides cross-linked with N,N r - methylene-bis-acrylamide; and silica.
  • the gel bead material can be cross-linked or non-cross-linked and be hydrophilic or hydrophobic.
  • Solution A 150 mM NaCl, 1 mM EDTA, 10 mM Tris-HCl (pH 7.4)
  • the liposome suspension had been prepared by applying 6-8.5 ml of 100 mM EYP solution on a Sephadex G-50 column and eluting with solution A at room temperature. Thereaf ⁇ ter, the liposome suspension had been concentrated, for example, by using a sample concentrator such as Minicon B (from Amicon). Suspensions of different phospholipid concentrations were used. In some cases, calcein was encapsulated in the liposomes. The tube was filled with nitrogen and sealed. The gel was mixed with the liposomes by vortexing and kept under nitrogen for at least 30 min to equilibrate the gel beads with the liposomes. For mixtures of high liposome concentrations longer times were used.
  • the mixture was frozen by immersing the tube into a dry ice/etha- nol bath (about -75°C) or into liquid nitrogen for 10 min and thawed in a 25°C water-bath. The tube was kept in the water-bath for 10 minutes.
  • Non-immobilized liposomes were removed with three portions of solution A by centrifugations at 150 x g for 3 x 5 min.
  • the gel with immobilized liposomes was packed into a column and further washed with at least 10 column volumes of solution A.
  • the immobilized liposomes were finally dissolved and eluted from the column with 50 mM cholate solution for determination of the immobilization capacity (the amount of immobilized phospholipids per gel volume) by a phosphorus assay according to the method of G.R. Bartlett, J. Biol. Chem. 234 (1959) 466.
  • the gel used was Sephacryl S-1000 in an amount corresponding to 0.5 ml packed volume.
  • the gel contained in a 10-ml roun -bottomed flask was immersed into dry-ice/ethanol and the gel-bead suspension was frozen to a thin shell while whirling the flask. Thereafter, the gel was freeze-dried at room temperature over ⁇ night. Then 1.1-1.2 ml of concentrated liposome suspension was introduced to the dried gel bead shell (76 mg).
  • the materials were mixed by vortexing and were kept under nitrogen at room temperature for about 3 h to swell the gel beads and to equilib ⁇ rate the gel beads with the liposomes.
  • the mixture was freeze- thawed as described in Example 1.
  • the washing procedures were also done as described in Example 1.
  • Example 1 The procedures described in the first paragraph of Example 1 were repeated with the exception that the mixture was frozen as a thin shell and not thawed. Thereafter, it was freeze-dried at room temperature overnight. Then the mixture in the thin shell was rehydrated with 1.1-1.2 ml of deionized water or diluted solution A to a final composition corresponding to solution A. Thereafter, the mixture was flushed with nitrogen gas and left under nitrogen at room temperature for at least 3 h to complete the rehydration process. Non-immobilized liposomes were removed by washing procedures as described above in Example 1.
  • the hydrated mixture can be freeze-thawed to increase the immobilization capacity.
  • Example 2 the procedures were the same as in Example 3, except that 1-2 ml of concentrated liposome suspension was added to the freeze-dried gel, which was kept under nitrogen at room temperature for 3 h. The mixture was then freeze-dried and rehydrated by addition of 1.1-1.2 ml of deionized water, diluted solution A or solution A. Washing procedures were done as described in Example 1 above.
  • the gel was freeze-dried as described in Example- 2.
  • Emulsion 1 200 mg of EYP was dissolved in 2 ml of diethyl ether in a 10-ml test tube fitted with a screw-cap lined with aluminium foil. 0.6 ml of solution A was rapidly injected into the lipid solution through a 0.4 mm x 20 mm needle from a 1 ml syringe. The solutions were mixed by use of a vortex mixer for 30 s and sonicated in a water-bath sonicator for 10 min.
  • Emulsion 2 200 mg of EYP was dissolved in 15 ml of diethyl ether solution in a 25-ml vial with a screw-cap. 1.5 ml of solution A was rapidly injected into the lipid solution as described above.
  • the solutions were mixed by use of a vortex mixer for 30 s and sonicated in a water-bath sonicator for 20 min.
  • Emulsifying an aqueous solution in an organic solution of EYP bv sonication.
  • Appropriate amounts (usually 40-100 mg) of EYP was dissolved in 5 ml of diethyl ether in a 100-ml flask.
  • Solution A or B with an appropriate volume (usually 0.6-2 ml) was added into the organic phase followed by water-bath sonication in a coldroom (5 C C) under protection of nitrogen gas for 5-10 min until a clear emulsion was obtained.
  • Such emulsion did not separate into two phases at room temperature during 30 min.
  • the shell mixture was converted to a viscous suspension as liposomes were formed, in case of emulsions which contained a relatively large volume ( ⁇ l.O ml) of aqueous solution.
  • ⁇ l.O ml a relatively large volume of aqueous solution.
  • the conversion from the shell mixture to the suspension occurred concomitant with formation of liposomes when the shell mixture was agitated vigorously by use of a vortex mixer, or when extra aqueous solution was added to the shell mixture.
  • the solvent-dried gel beads swoll to some extent upon hydration with water released from the emulsion.
  • Non-immobilized liposomes were removed by centrifugation and by column-washing as described i Example 1 above.
  • Procedures 1-4 above could be done in about 2 h.
  • the immobilization capacity increased almost linearly from 6.5 to 80 and from 3.5 to 40 ⁇ mol of phospholipids per milliliter of gel for Sephacryl S-1000 and for Sepharose 2B gels, respectively, with an increase in the liposome concentration up to 300 mM phospholipids (• and A in Fig. 1, respectively).
  • the capacity of immobilizing proteoliposomes with red cell membrane proteins was slightly lower than for liposomes without proteins (*, Fig. 1).
  • the amounts of EYP liposomes immobilized upon freezing and thawing were approximately twice as high in Sephacryl S-1000 (•, Fig. 1) as in Sepharose 2B gel ( A, Fig. 1).
  • Sephacryl S-1000 gel beads of allyldextran cross- linked with N,N-methylene-bis-acryl-amid has large pores and may be more accessible to large liposomes formed by freeze-thawing.
  • the higher immobilization capacity of Sephacryl S-1000 could be due to the fact that it was easier to drain more water from Sephacryl S-1000 than from Sepharose 2B gel by a water-jet pump. This might result in the uptake of more liposomes into the bead-pores of Sephacryl S-1000 compared to Sepharose 2B.
  • Control experiments showed that less than 1.3 and 0.7 ⁇ mol of phospholipids were adsorbed on Sephacryl S-1000 and on Sepharose 2B gels (o and ⁇ , Fig. 1), respectively, when liposomes .were mixed with the beads without subsequent freeze- thawing.
  • Liposomes could also be immobilized in some gels with relatively small pores by freeze-thaw immobilization according to Example 1 as shown below in Table 1. Table 1
  • the immobilization capacities of these gel were higher at 300 mM lipid concentration than was the 35 ⁇ mol/ml capacity of Sepharose 2B (A. Fig. 1), but lower than the corresponding 78 ⁇ mol/ml capacity of Sephacryl S-1000 ( ⁇ , Fig. 1).
  • Example 2 still higher capacities than in Example 1 were obtained when the gel beads were freeze-dried before mixing with liposome suspensions.
  • Table 2 Table 2
  • a 76 mg of freeze-dried gel corresponds to 0.5 ml of packed gel volume under the experimental conditions used.
  • the specific internal volume was determined by use of en ⁇ capsulated 10 mM calcein. It was 0.88 ⁇ l per ⁇ mol of phospholi ⁇ pids.
  • Example 1 Compared to the corresponding concentrations of Example 1 (see Fig. 1, •), the capacities increased by approximately 50% with a liposome concentration of 270 mM, and by approximately 120% with concentrations of 93 and 200 mM. Thus, a higher capacity was obtained at relatively lower concentration of liposomes.
  • Figure 2 shows a relatively high immobilization capacity, 62 ⁇ mol per ml gel, following freeze-drying and rehydration of a liposome suspension comprising 165 ⁇ mol phospholipids. It was noted that the capacities were increased by increasing the amounts of phospholipids in the above mentioned liposome suspensions having varying concentrations and volumes. Compared to the freeze- thawing procedure according to Example 1, an advantage of immobilization following freeze-drying and rehydration seems to be that high capacity can be obtained by using a lower concen ⁇ tration of liposomes.
  • Example 4 as Table 3 shows, high capacities were also obtained.
  • the specific internal volume was determined by use of en ⁇ capsulated 10 mM calcein. It was 0.54 ⁇ l per ⁇ mol of phospholipids. However, the specific internal volume of the liposomes was 38% lower than that obtained by the procedure in Example 2.
  • Liposomes could also be immobilized in Sephacryl S-1000 gel beads by steric immobilization according to Example 5.
  • Example 5 was 128 ⁇ mol of phospholipids per ⁇ l gel.
  • Figure 3 shows the total internal volumes and the specific internal volumes of immobilized EYP liposomes at varying concentrations.
  • EYP liposomes with encapsulated 10 mM calcein were immobilized in Sephacryl S-1000 by freeze-thawing according to Example 1.
  • the symbol ( ⁇ ) denotes specific internal volume of the immobilized liposomes expressed in ⁇ l per ⁇ mol phospholipid.
  • the symbol (o) denotes the total volume in ⁇ l per ml gel, which is calculated by multiplying the immobilization-capacities (data from Fig. 1, ⁇ ) with the specific internal volumes (•).
  • the liposome concentration thus affects the freeze-thaw fusion process.
  • the average size of the immobilized liposomes may decrease with increasing liposome concentration, but it is also possible that, the liposomes become multilamellar or multi- vesicular to a larger extent. It is known that small unilamellar vesicles prepared by sonication increase markedly in average size and in trapped volume upon freezing and thawing and upon freeze- drying and rehydration.
  • Liposomes could also be immobilized in Sephacryl S-1000 gel beads according to Example 6 as illustrated in Fig. 4, for the case of emulsification of 100 mg of EYP in an organic phase with the aqueous solution B, which contains calcein for determination of the internal volume.
  • the specific internal volume increased from 1.1 to 6.1 ⁇ l water per ⁇ mol phospholipid with a decrease of capacity from 60 to 12 ⁇ mol phospholipids per ml packed gel, when the volume of aqueous solution added for emulsification was increasd from 0.8 to 2.0 mi ' , as shown in Fig. 4A. Large liposomes.
  • Proteoliposomes immobilized at approximatively 10 ⁇ mol phospholipids per ml gel could be prepared by addition of integral membrane proteins from human red cells, solubilized in octyl glucoside to the immobili ⁇ zed liposomes pre-equilibrated with a low concentration of octyl glucoside.
  • the gel beads or similar materials produced according to the methods of the invention can be used as chromatographic media intended for a variety of applications as is apparent for a person skilled in the art.
  • Recent review articles are: Protein, Nuclic Acid and Enzyme 35 (1990) p 1983-1998, Kyoritsu Shuppan, Tokyo; and J. Chromatogr., Liposome chromatography: Liposomes immobilized in gel beads as a stationary phase for aqueous column chromatography, Per Lundahl and Qing Yang, in press.
  • Application can include biotechnical purposes, chemical synthesis and chemical analysis. For chemical synthesis catalytically active substances or macromolecules are incorporated into the liposomes or into their bilayers. Beads or particles with or without included, inserted or adsorbed substances or macromolecules are used for chemical analysis.
  • one or more pharmacologi ⁇ cally active drug(s) into the liposomes prior to or upon immobilizing thereof in gel beads or similar materials. This is readily accomplished by mixing the drug(s) with the liposomes or the lipid material upon or prior to immobilization.
  • the obtained gel beads or similar materials can then be implanted or injected in the human or animal body to serve as a drug delivery system having prolonged release of the drug(s) in vivo. Alternatively, they can be applicated, in any convenient form, onto the skin or other parts of the body to perform their intended action by diffusion of the drug(s).
  • immobilized liposomes with or without incorporated or encapsulated agents can be used for cosmetic purposes. Liposomes are well known as components in several cosmetic preparations and their action can be controlled by immobilization.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)

Abstract

On décrit des méthodes d'immobilisation de liposomes ou de protéoliposomes dans des matériaux réticulés ou non ayant un réseau à trois dimensions, par exemple des billes de gel ou des particules de gel, ou des billes ou des particules de matériaux similaires. Les liposomes sont rendus prisonniers dans le réseau ou les pores du gel ou du matériau par la formation de liposomes suffisamment grands à partir d'une suspension de liposomes ou d'une émulsion de lipides. Les méthodes comprennent: la préparation d'une suspension de liposomes et/ou des protéoliposomes, ou d'une émulsion de lipides, ou de lipides et de protéine(s), et d'eau dans un solvant organique; mélange du matériau avec la suspension ou l'émulsion; augmentation de la taille moyenne des liposomes et/ou des protéoliposomes qui sont passés dans le matériau, ou qui réalisent l'absorption et l'association de lipides (et de protéines(s)) émulsifiés dans le matériau par évaporation du solvant organique, avec formation de liposomes et/ou de protéoliposomes; et extraction des liposomes non immobilisés et/ou des protéoliposomes. Les billes de gel utilisées présentent une capacité d'immobilisation correspondant à au moins 20 νmol de phospholipides par ml de gel concentré, ou à un volume total interne de liposomes d'au moins 50 νmol par ml de gel. L'invention concerne des billes de gel ou des matériaux similaires avec des liposomes, protéoliposomes et/ou liposomes immobilisés, contenant des médicaments, substances ou macromolécules inclus ou introduits, ainsi que leur utilisation à des fins médicales vétérinaires, biotechnologiques, de synthèse, d'analyse et/ou cosmétiques.
PCT/SE1991/000788 1990-11-21 1991-11-20 Methodes d'immobilisation de liposomes dans des billes de gel et materiaux similaires presentant des liposomes immobilisees prepares par ces methodes, et leurs utilisations WO1992009267A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4500582A JPH06505913A (ja) 1990-11-21 1991-11-20 ゲルビーズ及び同様な材料においてリポソームを固定化する方法，このような方法によって調製された固定化リポソーム，及びそれらの使用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003706A SE9003706L (sv) 1990-11-21 1990-11-21 Metoder foer immobilisering av liposomer i gelkulor, och gelkulor med liposomer vilka immobiliserats med anvaendning av dessa metoder
SE9003706-0 1990-11-21

Publications (1)

Publication Number Publication Date
WO1992009267A1 true WO1992009267A1 (fr) 1992-06-11

Family

ID=20380966

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1991/000788 WO1992009267A1 (fr) 1990-11-21 1991-11-20 Methodes d'immobilisation de liposomes dans des billes de gel et materiaux similaires presentant des liposomes immobilisees prepares par ces methodes, et leurs utilisations

Country Status (5)

Country Link
EP (1) EP0559698A1 (fr)
JP (1) JPH06505913A (fr)
AU (1) AU8926891A (fr)
SE (1) SE9003706L (fr)
WO (1) WO1992009267A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003074691A1 (fr) * 2002-03-01 2003-09-12 National Institute Of Advanced Industrial Science And Technology Cellules et liposomes immobilises et procede d'immobilisation correspondant
WO2007014563A2 (fr) * 2005-08-04 2007-02-08 Intendis Gmbh Systeme gel-multiphase anhydre
AU2012261730B2 (en) * 2005-08-04 2014-05-08 Intendis Gmbh Anhydrous multiphase gel system

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6522387B2 (ja) * 2015-03-27 2019-05-29 株式会社キレートジャパン ハイドロゲル含有化粧料

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003640A1 (fr) * 1984-02-15 1985-08-29 The Liposome Company, Inc. Compositions de gels et de liposomes
EP0160266A2 (fr) * 1984-04-28 1985-11-06 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Composition de liposomes
WO1987001587A1 (fr) * 1985-09-17 1987-03-26 Biocompatibles Limited Microcapsules
US4921757A (en) * 1985-04-26 1990-05-01 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003640A1 (fr) * 1984-02-15 1985-08-29 The Liposome Company, Inc. Compositions de gels et de liposomes
EP0160266A2 (fr) * 1984-04-28 1985-11-06 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Composition de liposomes
US4921757A (en) * 1985-04-26 1990-05-01 Massachusetts Institute Of Technology System for delayed and pulsed release of biologically active substances
WO1987001587A1 (fr) * 1985-09-17 1987-03-26 Biocompatibles Limited Microcapsules

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Volume 106, No. 6, 9 February 1987, (Columbus, Ohio, US), G.J. FRASEN et al: "Critical parameters in freezing of liposomes", see page 350, Abstract 38358t, & Int. J. Pharm. 1986, 33(10), 27- 35. *
CHEMICAL ABSTRACTS, Volume 111, No. 13, 25 September 1989, (Columbus, Ohio, US), M. WALLSTEN et al: "Entrapment of lipid vesicles and membane protein-lipid vesicles in gel bead pores", see page 347, Abstract 111803u, & Biochim Biophys Acta 1989, 982 ( 1), 47- 52. *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003074691A1 (fr) * 2002-03-01 2003-09-12 National Institute Of Advanced Industrial Science And Technology Cellules et liposomes immobilises et procede d'immobilisation correspondant
US7501280B2 (en) 2002-03-01 2009-03-10 National Institute Of Advanced Industrial Science And Technology Immobilized cells and liposomes and method of immobilizing the same
WO2007014563A2 (fr) * 2005-08-04 2007-02-08 Intendis Gmbh Systeme gel-multiphase anhydre
WO2007014563A3 (fr) * 2005-08-04 2007-04-26 Intendis Gmbh Systeme gel-multiphase anhydre
EP2364693A3 (fr) * 2005-08-04 2013-02-27 Intendis GmbH Système gel-multiphase anhydre
CN101511339B (zh) * 2005-08-04 2013-09-11 因滕迪斯有限公司 无水多相凝胶体系
AU2012261730B2 (en) * 2005-08-04 2014-05-08 Intendis Gmbh Anhydrous multiphase gel system

Also Published As

Publication number Publication date
SE9003706D0 (sv) 1990-11-21
EP0559698A1 (fr) 1993-09-15
JPH06505913A (ja) 1994-07-07
SE9003706L (sv) 1992-05-22
AU8926891A (en) 1992-06-25

Similar Documents

Publication Publication Date Title
US5567433A (en) Liposome preparation and material encapsulation method
US4241046A (en) Method of encapsulating biologically active materials in lipid vesicles
US4235871A (en) Method of encapsulating biologically active materials in lipid vesicles
Yang et al. Steric immobilization of liposomes in chromatographic gel beads and incorporation of integral membrane proteins into their lipid bilayers
Mozafari Liposomes: an overview of manufacturing techniques
AU697484B2 (en) Preparation of multivesicular liposomes for controlled release of active agents
US4857319A (en) Method for preserving liposomes
KR100317751B1 (ko) 합성미립벡터및그제조방법
US4900556A (en) System for delayed and pulsed release of biologically active substances
US4853228A (en) Method of manufacturing unilamellar lipid vesicles
AU587600B2 (en) Method for preserving liposomes
EP0277776A2 (fr) Liposomes à noyaux solides
Lundahl et al. Liposome chromatography: liposomes immobilized in gel beads as a stationary phase for aqueous column chromatography
Yoshimoto et al. Immobilized liposome chromatography for studies of protein–membrane interactions and refolding of denatured bovine carbonic anhydrase
JPH02290241A (ja) カプセル充填法
US5173219A (en) Uniform spherical multilamellar liposomes of defined and adjustable size distribution
Brekkan et al. Properties of immobilized-liposome-chromatographic supports for interaction analysis
WO1992009267A1 (fr) Methodes d'immobilisation de liposomes dans des billes de gel et materiaux similaires presentant des liposomes immobilisees prepares par ces methodes, et leurs utilisations
Philippot et al. Extemporaneous preparation of large unilamellar liposomes
WO1989010116A1 (fr) Gelules
Goswami et al. A brief review on liposomal drug delivery system
Lundqvist et al. Freeze–thaw immobilization of liposomes in chromatographic gel beads: evaluation by confocal microscopy and effects of freezing rate
Arien et al. Encapsulation of calcitonin in liposome's depends on the vesicle preparation method
Hasan et al. Liposomes: An advance tools for novel drug delivery system
HANDA et al. Lyophilized liposomes prepared by a modified reversed-phase evaporation method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BG BR CA CS FI HU JP KP KR LK MC MG MN MW NO PL RO SD SU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU ML MR NL SE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 1991920486

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991920486

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1991920486

Country of ref document: EP